5,6-Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
11 2022
Historique:
revised: 21 07 2022
received: 31 05 2022
accepted: 03 08 2022
pubmed: 8 8 2022
medline: 29 10 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

Human skin contains two distinct components: brown to black, insoluble eumelanin and light colored, alkaline-soluble pheomelanin. Eumelanin consists of 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA) moieties, while pheomelanin consists of benzothiazine (BT) and benzothiazole (BZ) moieties. These melanin monomer units can be quantitatively analyzed through specific degradation products by high-performance liquid chromatography (HPLC). Alkaline hydrogen peroxide oxidation (AHPO) of eumelanin gives rise to pyrrole-2,3,5-tricarboxylic acid (PTCA) and pyrrole-2,3-dicarboxylic acid (PDCA) as specific degradation products of the DHICA and DHI moieties, respectively. BZ moiety in pheomelanin can be analyzed as thiazole-2,4,5-tricarboxylic acid (TTCA). By reductive hydrolysis with hydroiodic acid, BT moieties in pheomelanin can be analyzed as 4-amino-3-hydroxyphenylalanine (4-AHP). As a recently improved AHPO-HPLC method enabled a better characterization of PDCA, this prompted us to address the question of DHI to DHICA ratio in human skin samples with varying degrees of constitutive pigmentation ranging from very light to dark. Results showed for the first time the ratio of 4 moieties: DHI 35%, DHICA 41%, BZ 20%, and BT 4%. The ratio is constant regardless of the degree of pigmentation. The high content of DHICA moiety may impart an antioxidant property to the epidermis melanin.

Identifiants

pubmed: 35933709
doi: 10.1111/pcmr.13062
pmc: PMC9804219
doi:

Substances chimiques

eumelanin 12627-86-0
Melanins 0
5,6-dihydroxyindole Z3OC8499KG
Hydrogen Peroxide BBX060AN9V
Antioxidants 0
Pyrroles 0
Benzothiazoles 0
Tricarboxylic Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-626

Informations de copyright

© 2022 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd.

Références

Gastroenterology. 1979 May;76(5 Pt 1):958-64
pubmed: 220131
Photochem Photobiol. 2008 May-Jun;84(3):582-92
pubmed: 18435614
Int J Mol Sci. 2018 Sep 23;19(10):
pubmed: 30249034
Int J Mol Sci. 2018 Sep 08;19(9):
pubmed: 30205563
Free Radic Biol Med. 2010 May 1;48(9):1144-51
pubmed: 20123016
Anal Biochem. 2013 Mar 15;434(2):221-5
pubmed: 23256922
Angew Chem Int Ed Engl. 2013 Nov 25;52(48):12684-7
pubmed: 24123614
Folia Histochem Cytochem (Krakow). 1978;16(4):275-86
pubmed: 217805
Photochem Photobiol. 1985 Nov;42(5):529-32
pubmed: 4089035
Clin Biochem. 2005 Nov;38(11):997-1008
pubmed: 16139832
Sci Rep. 2017 Feb 02;7:41532
pubmed: 28150707
Pigment Cell Res. 1996 Oct;9(5):265-70
pubmed: 9014213
Pigment Cell Melanoma Res. 2012 Jul;25(4):434-45
pubmed: 22551214
Pigment Cell Res. 2002 Jun;15(3):225-32
pubmed: 12028587
Pigment Cell Res. 2000;13 Suppl 8:140-4
pubmed: 11041372
Pigment Cell Melanoma Res. 2015 Nov;28(6):707-17
pubmed: 26285058
Pigment Cell Res. 2002 Apr;15(2):119-26
pubmed: 11936269
PLoS Biol. 2003 Oct;1(1):E27
pubmed: 14551921
Pigment Cell Melanoma Res. 2014 Sep;27(5):721-33
pubmed: 24814217
Anal Biochem. 1985 Feb 1;144(2):527-36
pubmed: 3993914
Pigment Cell Melanoma Res. 2016 Jan;29(1):110-2
pubmed: 26451690
J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1369-80
pubmed: 22077870
J Am Chem Soc. 2014 Aug 20;136(33):11626-35
pubmed: 25078723
Pigment Cell Melanoma Res. 2009 Aug;22(4):474-86
pubmed: 19493317
Science. 1982 Aug 6;217(4559):545-7
pubmed: 6283638
Proc Natl Acad Sci U S A. 1982 May;79(9):2885-9
pubmed: 6283550
Pigment Cell Melanoma Res. 2011 Aug;24(4):605-13
pubmed: 21535429
J Invest Dermatol. 2000 Jun;114(6):1141-7
pubmed: 10844557
Int J Mol Sci. 2016 May 17;17(5):
pubmed: 27196900
Pigment Cell Res. 1993 Oct;6(5):348-53
pubmed: 8302773
Pigment Cell Res. 2003 Oct;16(5):434-47
pubmed: 12950718
Pigment Cell Res. 1997 Jun;10(3):158-61
pubmed: 9266603
Pigment Cell Melanoma Res. 2022 Nov;35(6):622-626
pubmed: 35933709
Experientia. 1977 Aug 15;33(8):1118-9
pubmed: 408183
J Am Acad Dermatol. 2002 Feb;46(2 Suppl Understanding):S41-62
pubmed: 11807469
Pigment Cell Melanoma Res. 2013 Nov;26(6):817-25
pubmed: 23844795
Int J Mol Sci. 2019 Jul 31;20(15):
pubmed: 31370161
Int J Mol Sci. 2020 Jul 20;21(14):
pubmed: 32698502

Auteurs

Sandra Del Bino (S)

L'Oreal Research and Innovation, Aulnay-sous-Bois, France.

Shosuke Ito (S)

Institute for Melanin Chemistry, Fujita Health University, Toyoake, Japan.

Juliette Sok (J)

L'Oreal Research and Innovation, Aulnay-sous-Bois, France.

Kazumasa Wakamatsu (K)

Institute for Melanin Chemistry, Fujita Health University, Toyoake, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH